Top

Published in:

20-02-2024 | Diabetic Retinopathy | Review Article

OCT angiography 2023 update: focus on diabetic retinopathy

Authors: Emanuele Crincoli, Riccardo Sacconi, Lea Querques, Giuseppe Querques

Published in: Acta Diabetologica | Issue 5/2024

Abstract

Optical coherence tomography angiography (OCTA) has become part of the clinical practice and its growing applications are in continuous development. Coherently with the growing concern about the human and economic cost of diabetes, diabetic retinopathy (DR) was the most popular topic for OCTA studies in the past year. The analysis of the literature reveals that applications of OCTA in DR are in continuous growth. In particular, ultrawide field (UWF) OCTA and artificial intelligence (AI) based on OCTA images are affirming as the new frontiers of scientific research in the field. Diagnostic accuracy of AI methods based on OCTA is equal or superior to the one based on OCT methods and also bears potential to detect systemic associations. UWF OCTA is noninvasive method that is reaching similar accuracy of FA in detection of neovascularization and intraretinal microvascular abnormalities (IRMAs) and has allowed better characterization of microvascular peripherical changes in DR. Lastly, deep capillary plexus (DCP) characteristics seem to play a pivotal role in the development of diabetic macular edema (DME) and refinement of biomarkers for different phenotypes of DME and diabetic macular ischemia (DMI) is currently on its way.

Crincoli E, Colantuono D, Zhao Z, Souied EH, Miere A (2022) Optical coherence tomography angiography for quantitative microvascular assessment in diabetic retinopathy: inter-device and intra-device agreement and correlation with clinical staging. Acta Diabetol. https://doi.org/10.1007/s00592-022-01921-zCrossRefPubMed

Crincoli E, Colantuono D, Miere A, Zhao Z, Ferrara S, Souied EH (2023) Perivenular capillary rarefaction in diabetic retinopathy: interdevice characterization and association to clinical staging. Ophthalmol Sci 3(2):100269. https://doi.org/10.1016/j.xops.2023.100269CrossRefPubMedPubMedCentral

Sun Z, Tang F, Wong R et al (2019) OCT angiography metrics predict progression of diabetic retinopathy and development of diabetic macular edema: a prospective study. Ophthalmology 126(12):1675–1684. https://doi.org/10.1016/j.ophtha.2019.06.016CrossRefPubMed

Kirthi V, Reed KI, Zuckerman K et al (2023) Multimodal testing reveals subclinical neurovascular dysfunction in prediabetes, challenging the diagnostic threshold of diabetes. Diabet Med 40(3):e14952. https://doi.org/10.1111/dme.14952CrossRefPubMed

Yao H, Li Z (2023) Is preclinical diabetic retinopathy in diabetic nephropathy individuals more severe? Front Endocrinol (Lausanne) 14:1144257. https://doi.org/10.3389/fendo.2023.1144257CrossRefPubMed

Wang D, Guo X, Wang W et al (2023) Longitudinal changes of parafoveal vessel density in diabetic patients without clinical retinopathy using optical coherence tomography angiography. Curr Eye Res. https://doi.org/10.1080/02713683.2023.2227363CrossRefPubMed

Gao W, Lin P, Li B et al (2023) Quantitative assessment of textural features in the early detection of diabetic retinopathy with optical coherence tomography angiography. Photodiagnosis Photodyn Ther 41:103214. https://doi.org/10.1016/j.pdpdt.2022.103214CrossRefPubMed

Dadzie AK, Le D, Abtahi M et al (2023) Normalized blood flow index in optical coherence tomography angiography provides a sensitive biomarker of early diabetic retinopathy. Transl Vis Sci Technol 12(4):3. https://doi.org/10.1167/tvst.12.4.3CrossRefPubMedPubMedCentral

Guo X, Chen Y, Bulloch G et al (2023) Parapapillary choroidal microvasculature predicts diabetic retinopathy progression and diabetic macular edema development: a three-year prospective study. Am J Ophthalmol 245:164–173. https://doi.org/10.1016/j.ajo.2022.07.008CrossRefPubMed

10.

Wang W, Guo X, Chen Y et al (2023) Choriocapillaris perfusion assessed using swept source optical coherence tomographic angiography and the severity of diabetic retinopathy. Br J Ophthalmol 107(6):836–841. https://doi.org/10.1136/bjophthalmol-2021-320163CrossRefPubMed

11.

Le D, Dadzie A, Son T, Lim JI, Yao X (2023) Comparative analysis of OCT and OCT angiography characteristics in early diabetic retinopathy. Retina. https://doi.org/10.1097/IAE.0000000000003761CrossRefPubMedPubMedCentral

12.

Srinivasan S, Sivaprasad S, Rajalakshmi R et al (2023) Association of OCT and OCT angiography measures with the development and worsening of diabetic retinopathy in type 2 diabetes. Eye (Lond). https://doi.org/10.1038/s41433-023-02605-wCrossRefPubMed

13.

Ong JX, Konopek N, Fukuyama H, Fawzi AA (2023) Deep capillary nonperfusion on OCT angiography predicts complications in eyes with referable nonproliferative diabetic retinopathy. Ophthalmol Retina 7(1):14–23. https://doi.org/10.1016/j.oret.2022.06.018CrossRefPubMed

14.

Yang D, Tang Z, Ran A et al (2023) Assessment of parafoveal diabetic macular ischemia on optical coherence tomography angiography images to predict diabetic retinal disease progression and visual acuity deterioration. JAMA Ophthalmol 141(7):641–649. https://doi.org/10.1001/jamaophthalmol.2023.1821CrossRefPubMed

15.

Ip M, Ribeiro ML, Santos TP et al (2023) Different risk profiles for progression of nonproliferative diabetic retinopathy: A 2-Year study. Ophthalmol Ther. https://doi.org/10.1007/s40123-022-00623-7CrossRefPubMedPubMedCentral

16.

Kim K, Kim ES, Yu S-Y (2023) Prediction of diabetic retinopathy severity using a combination of retinal neurodegeneration and capillary nonperfusion on optical coherence tomography angiography. Retina 43(8):1291–1300. https://doi.org/10.1097/IAE.0000000000003820CrossRefPubMed

17.

Sherif EM, Matter RM, Salah NY, Abozeid NEH, Atif HM, Tantawy NM (2023) Changes in early optical coherence tomography angiography among children and adolescents with type 1 diabetes: Relation to fibroblast growth factor 21. Diabetes Metab Res Rev 39(2):e3598. https://doi.org/10.1002/dmrr.3598CrossRefPubMed

18.

Diplotti L, Pignatto S, Franco F et al (2023) Ocular complications of diabetes mellitus in a pediatric population and proposals for screening and follow-up programs. Ther Adv Ophthalmol 15:25158414231174140. https://doi.org/10.1177/25158414231174141CrossRefPubMedPubMedCentral

19.

Cutruzzolà A, Carnevali A, Gatti V et al (2023) Continuous glucose monitoring-derived metrics and capillary vessel density in subjects with type 1 diabetes without diabetic retinopathy. J Diabetes Res 2023:9516059. https://doi.org/10.1155/2023/9516059CrossRefPubMedPubMedCentral

20.

Lobo C, Santos T, LMarques IP et al (2023) Characterisation of progression of macular oedema in the initial stages of diabetic retinopathy: a 3-year longitudinal study. Eye (Lond) 37(2):313–319. https://doi.org/10.1038/s41433-022-01937-3CrossRefPubMed

21.

Otani T, Kishi S, Maruyama Y (1999) Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 127(6):688–693. https://doi.org/10.1016/S0002-9394(99)00033-1CrossRefPubMed

22.

Sen S, Ramasamy K, Sivaprasad S (2021) Indicators of visual prognosis in diabetic macular oedema. J Personal Med. https://doi.org/10.3390/jpm11060449CrossRef

23.

Nassar GA, Maqboul IM, El-Nahry AG, Hassan LM, Shalash AB (2023) Macular vascular features of different types of diabetic macular edema using ocular coherence tomography angiography- a comparative study. Int J Retina Vitreous 9(1):32. https://doi.org/10.1186/s40942-023-00469-6CrossRefPubMedPubMedCentral

24.

Baldwin G, BVingopoulos F, Garg I et al (2023) Structure-function associations between contrast sensitivity and widefield swept-source optical coherence tomography angiography in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. https://doi.org/10.1007/s00417-023-06086-1CrossRefPubMed

25.

Wang Z, An H, Tang J et al (2023) Elevated number and density of macrophage-like cell as a novel inflammation biomarker in diabetic macular edema. Sci Rep 13(1):5320. https://doi.org/10.1038/s41598-023-32455-1CrossRefPubMedPubMedCentral

26.

Korobelnik J-F, Gaucher D, Baillif S, Creuzot-Garcher C, Kodjikian L, Weber M (2023) Optical coherence tomography angiography in diabetic macular edema treated with intravitreal aflibercept: a 48-week observational study (the DOCTA study). Ophthalmologica 246(2):71–80. https://doi.org/10.1159/000528426CrossRefPubMed

27.

Elnahry AG, Elnahry GA (2021) Optical coherence tomography angiography of macular perfusion changes after anti-VEGF therapy for diabetic macular edema: a systematic review. J Diabetes Res 2021:e6634637. https://doi.org/10.1155/2021/6634637CrossRef

28.

Zhang C-H, Gong B, Huang C et al (2023) Morphological and functional changes in the macular area in diabetic macular edema after a single intravitreal injection of aflibercept. Int J Ophthalmol 16(1):88–94. https://doi.org/10.18240/ijo.2023.01.13CrossRefPubMedPubMedCentral

29.

Li Z, Zhou L, Huang C et al (2023) Long-term real-world outcomes of retinal microvasculature changes in proliferative diabetic retinopathy treated with panretinal photocoagulation vs. intravitreal conbercept. Microvasc Res 150:104586. https://doi.org/10.1016/j.mvr.2023.104586CrossRefPubMed

30.

Viggiano P, Grassi MO, Bisceglia G et al (2023) Short-term peripapillary structural and vascular changes following anti-VEGF vs. Dexamethasone intravitreal therapy in patients with DME. Eur J Ophthalmol. https://doi.org/10.1177/11206721231163615CrossRefPubMed

31.

Kato F, Nozaki M, Kato A, Yasukawa T (2023) Retinal microvascular changes after intravitreal triamcinolone acetonide in diabetic macular edema. J Clin Med 12(10):3475. https://doi.org/10.3390/jcm12103475CrossRefPubMedPubMedCentral

32.

Serra R, Coscas F, Boulet JF et al (2023) Predictive factors of visual outcome in treatment-naïve diabetic macular edema: preliminary results from the clinical study ‘FOVEA.’ J Clin Med 12(12):3870. https://doi.org/10.3390/jcm12123870CrossRefPubMedPubMedCentral

33.

Hein M, Vukmirovic A, HConstable IJ et al (2023) Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema. Sci Rep 13(1):8128. https://doi.org/10.1038/s41598-023-35286-2CrossRefPubMedPubMedCentral

34.

Chouhan S, Kalluri Bharat RP, Surya J et al (2023) Preliminary report on optical coherence tomography angiography biomarkers in non-responders and responders to intravitreal anti-VEGF injection for diabetic macular oedema. Diagnostics (Basel) 13(10):1735. https://doi.org/10.3390/diagnostics13101735CrossRefPubMed

35.

Costanzo E, Giannini D, De Geronimo D, Fragiotta S, Varano M, Parravano M (2023) Prognostic imaging biomarkers in diabetic macular edema eyes treated with intravitreal dexamethasone implant. J Clin Med 12(4):1303. https://doi.org/10.3390/jcm12041303CrossRefPubMedPubMedCentral

36.

Cennamo G, Montanaro L, Massa L, Malvone E, Costagliola C (2023) Evaluation of changes in epivascular glia before and after intravitreal dexamethasone implant: An OCT pilot study. Photodiagnosis Photodyn Ther 43:103688. https://doi.org/10.1016/j.pdpdt.2023.103688CrossRefPubMed

37.

Tsai W-S, Thottarathsai S, Gurudas S et al (2023) Characterization of the structural and functional alteration in eyes with diabetic macular ischemia. Ophthalmol Retina 7(2):142–152. https://doi.org/10.1016/j.oret.2022.07.010CrossRefPubMed

38.

Tan B, Lim NA, Tan R et al (2023) Combining retinal and choroidal microvascular metrics improves discriminative power for diabetic retinopathy. Br J Ophthalmol 107(7):993–999. https://doi.org/10.1136/bjophthalmol-2021-319739CrossRefPubMed

39.

Deng X, Li Z, Zeng P, Liang J, Wang J, Lan Y (2023) The association between decreased choriocapillary flow and electroretinogram impairments in patients with diabetes. Photodiagnosis Photodyn Ther 42:103547. https://doi.org/10.1016/j.pdpdt.2023.103547CrossRefPubMed

40.

Su R, Qi Z, Tan X (2023) Macular choroidal thickness and choriocapillaris vessel density alterations in type 2 diabetics with high myopia. Ophthalmic Res. https://doi.org/10.1159/000529348CrossRefPubMed

41.

Decker NL, Duffy BV, Boughanem GO et al (2023) Macular perfusion deficits on OCT angiography correlate with nonperfusion on ultrawide-field fluorescein angiography in diabetic retinopathy. Ophthalmol Retina 7(8):692–702. https://doi.org/10.1016/j.oret.2023.04.003CrossRefPubMed

42.

Shah PN, Mishar DK, Falahat P et al (2023) Inter-rater reliability of proliferative diabetic retinopathy assessment on wide-field OCT-angiography and fluorescein angiography. Transl Vis Sci Technol 12(7):13. https://doi.org/10.1167/tvst.12.7.13CrossRefPubMedPubMedCentral

43.

Yang Y, Li F, Liu T, Jiao W, Zhao B (2023) Comparison of widefield swept-source optical coherence tomographic angiography and fluorescein fundus angiography for detection of retinal neovascularization with diabetic retinopathy. BMC Ophthalmol 23(1):315. https://doi.org/10.1186/s12886-023-03073-2CrossRefPubMedPubMedCentral

44.

Hirano T, Hoshiyama K, Takahashi Y, Murata T (2023) Wide-field swept-source OCT angiography (23 × 20 mm) for detecting retinal neovascularization in eyes with proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 261(2):339–344. https://doi.org/10.1007/s00417-022-05878-1CrossRefPubMed

45.

Bajka A, Bacci T, Wiest MRJ et al (2023) Feasibility and clinical utility of wide-field optical coherence tomography angiography compared to ultrawide-field fluorescein angiography in patients with diabetic retinopathy. Klin Monbl Augenheilkd 240(4):490–495. https://doi.org/10.1055/a-2031-2657CrossRefPubMed

46.

Li M, Mao M, Wei D et al (2023) Different scan areas affect the detection rates of diabetic retinopathy lesions by high-speed ultra-widefield swept-source optical coherence tomography angiography. Front Endocrinol (Lausanne). https://doi.org/10.3389/fendo.2023.1111360CrossRefPubMedPubMedCentral

47.

Tsuboi K, Mazloumi M, Guo Y et al (2023) Utility of en face OCT for the detection of clinically unsuspected retinal neovascularization in patients with diabetic retinopathy. Ophthalmol Retina 7(8):683–691. https://doi.org/10.1016/j.oret.2023.03.002CrossRefPubMed

48.

Menean M, Sacconi R, Tombolini B, Fantaguzzi F, Bandello F, Querques G (2023) Combined wide-field imaging in grading diabetic retinopathy. Eye (Lond). https://doi.org/10.1038/s41433-023-02666-xCrossRefPubMed

49.

Zeng Y, Liu M, Li M et al (2023) Early changes to retinal structure in patients with diabetic retinopathy as determined by ultrawide swept-source optical coherence tomography-angiography. Front Endocrinol (Lausanne). https://doi.org/10.3389/fendo.2023.1143535CrossRefPubMedPubMedCentral

50.

Zhao Q, Wang C, Meng L et al (2023) Central and peripheral changes in the retina and choroid in patients with diabetes mellitus without clinical diabetic retinopathy assessed by ultra-wide-field optical coherence tomography angiography. Front Public Health 11:1194320. https://doi.org/10.3389/fpubh.2023.1194320CrossRefPubMedPubMedCentral

51.

Qi Z, Si Y, Feng F et al (2023) Analysis of retinal and choroidal characteristics in patients with early diabetic retinopathy using WSS-OCTA. Front Endocrinol (Lausanne). https://doi.org/10.3389/fendo.2023.1184717CrossRefPubMed

52.

Xu F, Li Z, Yang X et al (2022) Assessment of choroidal structural changes in patients with pre- and early-stage clinical diabetic retinopathy using wide-field SS-OCTA. Front Endocrinol (Lausanne). https://doi.org/10.3389/fendo.2022.1036625CrossRefPubMedPubMedCentral

53.

Li F, Liu L, Rao C-H, Gao J (2023) Comparison of chorioretinal parameters in diabetic retinopathy with or without pan-retinal photocoagulation using ultrawide-field swept-source optical coherence tomography angiography. Ophthalmic Res 66(1):538–549. https://doi.org/10.1159/000529335CrossRefPubMed

54.

Le R, Cui Y, Lu ES et al (2023) Prevalence of venous loops and association with retinal ischemia in diabetic retinopathy using widefield swept-source OCT angiography. Graefes Arch Clin Exp Ophthalmol 261(7):1861–1870. https://doi.org/10.1007/s00417-022-05957-3CrossRefPubMed

55.

Ipp E, Liljenquist D, Bode B et al (2021) Pivotal evaluation of an artificial intelligence system for autonomous detection of referrable and vision-threatening diabetic retinopathy. JAMA Netw Open 4(11):e2134254. https://doi.org/10.1001/jamanetworkopen.2021.34254CrossRefPubMedPubMedCentral

56.

Matten P, Scherer J, Schlegl T et al (2023) Multiple instance learning based classification of diabetic retinopathy in weakly-labeled widefield OCTA en face images. Sci Rep 13(1):8713. https://doi.org/10.1038/s41598-023-35713-4CrossRefPubMedPubMedCentral

57.

Zang P, Hormel TT, Wang J et al (2023) Interpretable diabetic retinopathy diagnosis based on biomarker activation map. IEEE Trans Biomed Eng. https://doi.org/10.1109/TBME.2023.3290541CrossRefPubMedPubMedCentral

58.

Carrera-Escalé L, Benali A, Rathert AC et al (2023) Radiomics-based assessment of OCT angiography images for diabetic retinopathy diagnosis. Ophthalmol Sci 3(2):100259. https://doi.org/10.1016/j.xops.2022.100259CrossRefPubMed

59.

Khalili Pour E, Rezaee K, Azimi H et al (2023) Automated machine learning-based classification of proliferative and non-proliferative diabetic retinopathy using optical coherence tomography angiography vascular density maps. Graefes Arch Clin Exp Ophthalmol 261(2):391–399. https://doi.org/10.1007/s00417-022-05818-zCrossRefPubMed

60.

Xiong H, You QS, Guo Y et al (2023) Deep learning-based signal-independent assessment of macular avascular area on 6×6 mm optical coherence tomography angiogram in diabetic retinopathy: a comparison to instrument-embedded software. Br J Ophthalmol 107(1):84–89. https://doi.org/10.1136/bjophthalmol-2020-318646CrossRefPubMed

Title: OCT angiography 2023 update: focus on diabetic retinopathy
Authors: Emanuele Crincoli
Riccardo Sacconi
Lea Querques
Giuseppe Querques
Publication date: 20-02-2024
Publisher: Springer Milan
Keywords: Diabetic Retinopathy
Ophthalmology
Angiography
Artificial Intelligence
Type 1 Diabetes
Type 2 Diabetes
Diabetic Retinopathy
Metabolic Disease and Nutrition
Published in: Acta Diabetologica / Issue 5/2024
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-024-02238-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Angiogram of diabetic retinopathy/© (M) Crincoli, E et al. Acta Diabetologica https://doi.org/10.1007/s00592-024-02238-9 © 2024, Springer-Verlag Italia S.r.l., part of Springer Nature., Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2024

Network analysis of depression, cognitive functions, and suicidal ideation in patients with diabetes: an epidemiological study in Iran

Continuous improvement of quality of care in pediatric diabetes: the ISPED CARD clinical registry

Sintilimab-induced autoimmune diabetes mellitus manifesting as diabetic ketoacidosis in a patient with advanced esophageal squamous cell carcinoma

Effect of a multidisciplinary team approach in patients with diabetic foot ulcers on major adverse limb events (MALEs): systematic review and meta-analysis for the development of the Italian guidelines for the treatment of diabetic foot syndrome

Association of carotid atherosclerosis markers with all-cause and cardiovascular disease–specific mortality in persons with type 2 diabetes: a causal mediation analysis with glucose variation

Association of pro-inflammatory cytokines, adipokines and hepatokine with incident diabetes in India: a nested case–control study within CARRS cohort

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage